Skip to main content
. 2020 Jan 13;102(3):547–552. doi: 10.4269/ajtmh.19-0390

Table 1.

Salient demographics, and clinical and histopathological characteristics in the six leprosy patients with resistant mutations

Variables Case 1 Case 2 Case 3 Case 4 Case 5 Case 6
Place of origin Darjeeling, West Bengal Nepal Kadapa, Andhra Pradesh Dharbhanga, Bihar Dhubri, Assam Chikkaballapur, Karnataka
Year of evaluation 2008 2013 2014 2015 2017 2018
Endemic region No No No Yes No No
Follow-up in December 2018 Lost Lost Deficits stable. MDT for 12 months 5 years ago. No active disease Lost Deficits stable. On MDT for 12 months Deficits stable. Stopped MDT after the 12-month course
Gender M M M F M M
Age at presentation (years) 45 22 61 14 32 24
Age at onset (years) 33 20 60 13 31 22
Duration of illness (months) 144 24 18 12 24 48
Affected limb(s) Lower limbs Lower limbs Upper limbs Right upper limb Lower limbs Right upper limb
Histopathology diagnosis BT BT BL BT BT BT
Biopsied nerve DCUN Superficial peroneal nerve DCUN DCUN SRN SRN
Histopathology findings
 Plasma cells Yes
 Histiocytes Yes Yes Yes
 Lymphocytes Yes Yes Yes Yes Yes Yes
Perineurial thickening Yes Yes Yes Yes Yes Yes
 Endoneurial thickening Yes Yes Yes Yes Yes Yes
 Perivascular inflammation Yes Yes Yes Yes Yes Yes
 Giant cells Yes
 Foam cells Yes
 Caseous necrosis Yes
 AFB No No Yes No No No
 Skin lesions Yes Yes No No Yes Yes
 Hypopigmented patches Yes Yes Yes
 Nonhealing ulcers Yes Yes
Mutations in drug resistance–determining region
 Dapsone Pro55Ser Pro55Lue
 Rifampicin Lue436Gln
 Ofloxacin Ala91Pro Ala91Pro Gly89Ala Gly89Cys Ala91Val
 Prior drug therapy None None None None None None

BT = borderline tuberculoid; DCUN = dorsal cutaneous branch of ulnar nerve; SRN = superficial radial nerve.